Thermo Fisher Scientific Stock Hits Day Low Amid Price Pressure at $455.60

Thermo Fisher Scientific, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock dropping by 9.2% as of April 23, 2026. The stock reached an intraday low of USD 455.60, reflecting a challenging trading environment. Over the past week, Thermo Fisher has seen a decrease of 9.55%, while its performance over the last month shows a decline of 2.39%. In contrast, the S&P 500 has posted a modest gain of 0.95% for the week and 8.01% for the month. Year-to-date, Thermo Fisher's stock is down 19.46%, significantly underperforming the S&P 500, which has gained 3.84% during the same period. Despite these recent setbacks, the company maintains a strong ability to service its debt, evidenced by a healthy EBIT to Interest ratio of 11.00. Additionally, Thermo Fisher has demonstrated long-term growth potential, with net sales increasing at an annual rate of 10.48%. The stock is currently trading at a discount compared to its peers, indicating a potentially attractive valuation in the market.